Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

Chen 2017.

Study characteristics
Methods Randomised, placebo‐controlled, double‐blind trial
Participants Diagnosis: DSM‐IV‐TR major depressive episode
N: 132 randomised, 127 completed the study
Age: ketamine 0.3 mg/kg group M = 40.94 (SD = 15.41); placebo saline group M = 37.44 (SD = 14.16)
Sex: ketamine 0.3 mg/kg group 66.7% female; placebo saline group 64.1% female
Baseline depression severity: ketamine 0.3mg/kg group HAM‐D score M = 38.05 (SD = 3.23); placebo saline group HAM‐D score M = 37.43 (SD = 2.64)
Interventions Patients assigned to the study group were anesthetised using 1.5 mg/kg propofol and 0.3 mg/kg ketamine delivered intravenously. Patients assigned to the control group were anesthestised using 1.5 mg/kg propofol and normal saline. The ECT was administered 3 times a week (12 sessions of ECT in total).
Ketamine 0.3 mg/kg group (N = 63)
Placebo saline group (N = 64)
Concomitant treatment: Not reported
Outcomes Wechsler Memory Scale‐Chinese Revision (WMS‐RC)
MMSE
HAM‐D
Remission rates (sustained HAM‐D score <10 after 2 consecutive ECTs)
4‐item positie symptom subscale of the Brief Psychatric Rating Scale (BPRS+)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "All recruited participants were randomly assigned into 1 of 2 groups: the control group and the study group. Half the patients were placed in each group using a computer‐generated random number table." No further details given.
Allocation concealment (selection bias) Low risk Quote: "The patients, treatment teams, and the outcome assessors were all blinded to the intervention allocation."
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Blinding stated but not tested. Quote: "The anesthesiologists, patients, and outcome raters were all blind to the group assignments and the anesthetic regimen."
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding stated but not tested. Ketamine and normal saline were both prepared before each ECT treatment, quote: "by a specialized nurse who was blind to the study design".
Incomplete outcome data (attrition bias)
All outcomes Low risk Exclusion and withdrawal rates at each time point are recorded
Selective reporting (reporting bias) Unclear risk Protocol unavailable
Other bias Low risk No other potential sources of bias identified